396 related articles for article (PubMed ID: 21123333)
21. HLA-B27: a registry of constitutive peptide ligands.
Lopez de Castro JA; Alvarez I; Marcilla M; Paradela A; Ramos M; Sesma L; Vázquez M
Tissue Antigens; 2004 May; 63(5):424-45. PubMed ID: 15104674
[TBL] [Abstract][Full Text] [Related]
22. [Advance of research on HLA-B27 and the immunological mechanism of ankylosing spondylitis].
Li MY; Yao ZQ; Liu XY
Sheng Li Ke Xue Jin Zhan; 2011 Feb; 42(1):16-20. PubMed ID: 21595182
[TBL] [Abstract][Full Text] [Related]
23. Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis.
Fert I; Cagnard N; Glatigny S; Letourneur F; Jacques S; Smith JA; Colbert RA; Taurog JD; Chiocchia G; Araujo LM; Breban M
Arthritis Rheumatol; 2014 Apr; 66(4):841-51. PubMed ID: 24757137
[TBL] [Abstract][Full Text] [Related]
24. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Vázquez MN; López de Castro JA
Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
[TBL] [Abstract][Full Text] [Related]
25. The pathogenetic role of HLA-B27 and its subtypes.
Khan MA; Mathieu A; Sorrentino R; Akkoc N
Autoimmun Rev; 2007 Jan; 6(3):183-9. PubMed ID: 17289555
[TBL] [Abstract][Full Text] [Related]
26. HLA-B27 and the pathogenesis of spondyloarthropathies.
López de Castro JA
Immunol Lett; 2007 Jan; 108(1):27-33. PubMed ID: 17129613
[TBL] [Abstract][Full Text] [Related]
27. The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
Blanco-Gelaz MA; Suárez-Alvarez B; González S; López-Vázquez A; Martínez-Borra J; López-Larrea C
Int Immunol; 2006 Jan; 18(1):211-20. PubMed ID: 16361312
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of disease: infection and spondyloarthritis.
Inman RD
Nat Clin Pract Rheumatol; 2006 Mar; 2(3):163-9. PubMed ID: 16932676
[TBL] [Abstract][Full Text] [Related]
29. Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.
Czitrom AA; Pototschnik R; Edwards S; Gladman DD; Falk JA
Exp Clin Immunogenet; 1986; 3(3):129-37. PubMed ID: 2484102
[TBL] [Abstract][Full Text] [Related]
30. HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides.
Milia AF; Ibba-Manneschi L; Manetti M; Benelli G; Messerini L; Matucci-Cerinic M
Ann N Y Acad Sci; 2009 Sep; 1173():570-4. PubMed ID: 19758201
[TBL] [Abstract][Full Text] [Related]
31. [Spondylarthritis ankylopoietica and HLA-B27].
Benevolenskaia LI
Ter Arkh; 1992; 64(5):106-10. PubMed ID: 1455363
[TBL] [Abstract][Full Text] [Related]
32. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis.
Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA
Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853
[TBL] [Abstract][Full Text] [Related]
33. Current controversies in spondyloarthritis: SPARTAN.
Weisman M; Learch TJ; Baraliakos X; Chandran V; Gladman DD; Raychaudhuri SP; Xu H; Collantes-Estévez E; Vázquez-Mellado J; Mease PJ; Sieper J; Deodhar AA; Colbert RA; Clegg DO;
J Rheumatol; 2010 Dec; 37(12):2617-23. PubMed ID: 21123334
[TBL] [Abstract][Full Text] [Related]
34. HLA-B27 structure, function, and disease association.
López-Larrea C; Gonzalez-Roces S; Alvarez V
Curr Opin Rheumatol; 1996 Jul; 8(4):296-308. PubMed ID: 8864580
[TBL] [Abstract][Full Text] [Related]
35. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
García-Peydró M; Martí M; López de Castro JA
J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
[TBL] [Abstract][Full Text] [Related]
36. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease.
Turner MJ; Delay ML; Bai S; Klenk E; Colbert RA
Arthritis Rheum; 2007 Jan; 56(1):215-23. PubMed ID: 17195225
[TBL] [Abstract][Full Text] [Related]
37. HLA-B27.
Bowness P
Annu Rev Immunol; 2015; 33():29-48. PubMed ID: 25861975
[TBL] [Abstract][Full Text] [Related]
38. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
[TBL] [Abstract][Full Text] [Related]
39. Animal models of spondyloarthritis.
Lories RJ
Curr Opin Rheumatol; 2006 Jul; 18(4):342-6. PubMed ID: 16763452
[TBL] [Abstract][Full Text] [Related]
40. [New pathogenetic aspects of ankylosing spondylitis].
Schmidt KL
Z Rheumatol; 1991; 50(2):65-73. PubMed ID: 1872044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]